NK cells expressing killer cell inhibitory receptors after allogeneic bone marrow transplantation

Transplantation Proceedings

Volumn 32, Issue 7, 2000, Pages 2447-

  Tanaka, J ^a   Kobayashi, S ^a   Mori, A ^a   Ohta, S ^a   Hashino, S ^a   Kasai, M ^b   Asaka, M ^a   Imamura, M ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SAPPORO HOKUYU HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD158 ANTIGEN; CD3 ANTIGEN; CYCLOSPORIN; HLA C ANTIGEN; KILLER CELL INHIBITORY RECEPTOR; METHOTREXATE; TACROLIMUS; UNCLASSIFIED DRUG;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; NATURAL KILLER CELL; PRIORITY JOURNAL;

ANTIGENS, CD3; BONE MARROW TRANSPLANTATION; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC; REFERENCE VALUES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033673818     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)01736-X     Document Type: Article

References (5)

1. Ljunggren HG, Karre K: Immunol Today 11:237, 1990
2. Moretta A, Biassoni R, Bottino C, et al: Immunol Rev 155:105, 1997
3. Biassoni R, Falco M, Cambiaggi A, et al: J Exp Med 182:605, 1995
4. Murphy WJ, Reynolds CW, Tiberghien P, et al: J Natl Cancer Inst 85:1475, 1993
5. Young NT, Bunce M, Morris PJ, et al: Human Immunol 52:1, 1997